Finafloxacin Production Cost Reports

The report provides a detailed analysis essential for establishing a Finafloxacin production plant. It encompasses all critical aspects necessary for Finafloxacin production, including the cost of Finafloxacin production, Finafloxacin plant cost, Finafloxacin production costs, and the overall Finafloxacin production plant cost. Additionally, the study covers specific expenditures associated with setting up and operating a Finafloxacin production plant. These encompass production processes, raw material requirements, utility requirements, infrastructure needs, machinery and technology requirements, manpower requirements, packaging requirements, transportation requirements, and more.

Finafloxacin is a fluoroquinolone antibiotic mainly used to treat ear infections, especially those that worsen in moist or acidic conditions. It is mainly used in the treatment of acute otitis externa, which is commonly known as swimmer’s ear, caused by susceptible bacteria. Its unique ability to remain active in low pH conditions makes it particularly suitable for infections in inflamed or infected tissues. Moreover, it is also being studied for its potential use in treating urinary tract infections and respiratory infections. Its availability in topical and oral formulations provides flexibility in treatment based on the type and severity of the infection. It is also used in controlled medical settings to manage stubborn infections that do not respond well to other antibiotics. Overall, it serves as a valuable option in modern infectious disease management due to its strong antibacterial properties and improved effectiveness in acidic conditions.

The market for Finafloxacin is mainly driven by its demand as a fluoroquinolone antibiotic with enhanced activity in acidic environments, which makes it highly effective in treating bacterial infections. Its usage as ear drops for the treatment of acute otitis externa, which helps reduce pain, swelling, and bacterial growth, also strengthens its demand in the healthcare and pharmaceutical industries. Its demand as a medication in research settings to understand its effectiveness in harsher environments and its potential in treating other localised bacterial infections also fuels its market expansion.

The rising concern over antibiotic resistance and the growing need for advanced antibacterial agents largely support its market expansion. Additionally, industrial Finafloxacin procurement is shaped by factors such as the cost and availability of key intermediates, regulatory approvals, and adherence to environmental safety standards. Advancements in chemical synthesis, consistent product quality, supplier dependability, and efficient global logistics further influence procurement strategies for Finafloxacin.

Raw Material for Finafloxacin Production

According to the Finafloxacin production plant project report, the major raw materials for Finafloxacin production include 5-Fluoro-1,3-xylene, Hydroxylamine Hydrochloride, Thionyl Chloride, Ethyl 3-dimethylaminoacrylate, Cyclopropylamine, Pyrrolo-oxazine derivative, and Triethylamine.

Production Process of Finafloxacin

The extensive Finafloxacin production cost report consists of the following industrial production process:

1. Production via Chemical Synthesis: The production process of Finafloxacin begins with 5-fluoro-1,3-xylene, which first undergoes catalytic chlorination followed by photochemical chlorination to produce a polychlorinated intermediate. Then, the compound is hydrolysed using concentrated sulfuric acid to give 3-formylbenzoic acid. The aldehyde group is converted to a nitrile, and the carboxylic acid is transformed into an acid chloride through a two-step process involving hydroxylamine hydrochloride and thionyl chloride. Then, this acid chloride is reacted with ethyl 3-dimethylaminoacrylate, followed by condensation with cyclopropylamine, base treatment, and acidification to generate an ethyl ester intermediate. This ester is hydrolysed to the corresponding acid, which is coupled with a pyrrolo-oxazine fragment in the presence of triethylamine in warm acetonitrile to obtain high-purity Finafloxacin.

Finafloxacin is a fluoroquinolone antimicrobial agent of the 8-cyano subclass that is used to treat acute bacterial external ear infections. The compound shows enhanced activity in acidic environments. It exists as an odourless, white to off-white crystalline powder. The molecular formula of the free base is C20H19FN4O4, and its molecular weight is 398.39 g/mol. The density of the solid is about 1.6 g/cm³. The boiling point of the compound is near 686 degree Celsius and its flash point is around 369 degree Celsius. Its hydrochloride salt form decomposes above about 210 degree Celsius. The compound is sparingly soluble in water but more soluble in organic solvents such as DMSO. It should be handled and used under appropriate professional guidance, as it is an antibiotic. Additionally, fluoroquinolones can cause adverse effects, such as gastrointestinal and neurological reactions in some patients.